Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, Bruna C, Vincenti A, Verlato R; PAF 2 Study Investigators. Brignole M, et al. Among authors: gasparini m. Eur Heart J. 2002 Jun;23(11):892-900. doi: 10.1053/euhj.2001.2971. Eur Heart J. 2002. PMID: 12042011 Clinical Trial.
Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation.
Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, Raviele A, Lolli G, Paparella N, Acquarone S. Brignole M, et al. Among authors: gasparini m. Europace. 1999 Jan;1(1):15-9. doi: 10.1053/eupc.1998.0007. Europace. 1999. PMID: 11220531 Clinical Trial.
Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.
Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, Raviele A, Lolli G, Paparella N, Acquarone S. Brignole M, et al. Among authors: gasparini m. Circulation. 1997 Oct 21;96(8):2617-24. doi: 10.1161/01.cir.96.8.2617. Circulation. 1997. PMID: 9355902 Clinical Trial.
Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry.
Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, Santini M, Padeletti L, Molon G, Botto G, De Santo T, Valsecchi S; InSync/InSync ICD Italian Registry Investigators. Boriani G, et al. Among authors: gasparini m. Eur Heart J. 2009 Sep;30(18):2275-83. doi: 10.1093/eurheartj/ehp226. Epub 2009 Jun 10. Eur Heart J. 2009. PMID: 19515689 Free PMC article.
AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E, Calò L, Mascia G, Mont L, Vernooy K, van Dijk V, Allaart C, Fauchier L, Gasparini M, Parati G, Soranna D, Rienstra M, Van Gelder IC; APAF-CRT Trial Investigators. Brignole M, et al. Among authors: gasparini m. Eur Heart J. 2021 Dec 7;42(46):4731-4739. doi: 10.1093/eurheartj/ehab569. Eur Heart J. 2021. PMID: 34453840 Clinical Trial.
Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.
Puglisi A, Gasparini M, Lunati M, Sassara M, Padeletti L, Landolina M, Botto GL, Vincenti A, Bianchi S, Denaro A, Grammatico A, Boriani G; InSync III Italian Registry Investigators. Puglisi A, et al. Among authors: gasparini m. J Cardiovasc Electrophysiol. 2008 Jul;19(7):693-701. doi: 10.1111/j.1540-8167.2007.01093.x. Epub 2008 Mar 4. J Cardiovasc Electrophysiol. 2008. PMID: 18328039 Clinical Trial.
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.
Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. Gasparini M, et al. Eur Heart J. 2009 Nov;30(22):2758-67. doi: 10.1093/eurheartj/ehp247. Epub 2009 Jun 29. Eur Heart J. 2009. PMID: 19567380 Free PMC article. Clinical Trial.
489 results